APA (7th ed.) Citation

JP, K., H, L., BH, K., H, K., D, S., S, Y., . . . HN, K. (2026). Genetically prioritized druggable targets for amyloid-β pathology highlight ACE as a therapeutic candidate in Alzheimer's disease. Journal of Alzheimer's disease : JAD, 13872877261454540. https://doi.org/10.1177/13872877261454540

Chicago Style (17th ed.) Citation

JP, Kim, Lee H, Kim BH, Kang H, Shin D, Yim S, Kim S, Seo SW, and Kim HN. "Genetically Prioritized Druggable Targets for Amyloid-β Pathology Highlight ACE as a Therapeutic Candidate in Alzheimer's Disease." Journal of Alzheimer's Disease : JAD 2026: 13872877261454540. https://doi.org/10.1177/13872877261454540.

MLA (9th ed.) Citation

JP, Kim, et al. "Genetically Prioritized Druggable Targets for Amyloid-β Pathology Highlight ACE as a Therapeutic Candidate in Alzheimer's Disease." Journal of Alzheimer's Disease : JAD, 2026, p. 13872877261454540, https://doi.org/10.1177/13872877261454540.